MwanzoOGN • NYSE
add
Organon & Co
Bei iliyotangulia
$ 9.98
Bei za siku
$ 9.73 - $ 10.14
Bei za mwaka
$ 8.01 - $ 23.10
Thamani ya kampuni katika soko
2.57B USD
Wastani wa hisa zilizouzwa
4.73M
Uwiano wa bei na mapato
3.40
Mgao wa faida
0.82%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.51B | -6.72% |
Matumizi ya uendeshaji wa biashara | 516.00M | -4.97% |
Mapato halisi | 87.00M | -56.72% |
Kiwango cha faida halisi | 5.75 | -53.59% |
Mapato kwa kila hisa | 1.02 | -16.39% |
EBITDA | 409.00M | -14.61% |
Asilimia ya kodi ya mapato | 13.86% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 547.00M | -4.87% |
Jumla ya mali | 13.16B | 10.64% |
Jumla ya dhima | 12.61B | 6.51% |
Jumla ya hisa | 542.00M | — |
hisa zilizosalia | 259.96M | — |
Uwiano wa bei na thamani | 4.75 | — |
Faida inayotokana na mali | 6.19% | — |
Faida inayotokana mtaji | 8.55% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 87.00M | -56.72% |
Pesa kutokana na shughuli | 75.00M | -1.32% |
Pesa kutokana na uwekezaji | -172.00M | -79.17% |
Pesa kutokana na ufadhili | -75.00M | -1.35% |
Mabadiliko halisi ya pesa taslimu | -128.00M | -8.47% |
Mtiririko huru wa pesa | -73.38M | -288.75% |
Kuhusu
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Ilianzishwa
1923
Makao Makuu
Tovuti
Wafanyakazi
10,000
